Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
o-Cymen-5-ol is a synthetic small molecule belonging to the isopropyl cresols family and is structurally related to thymol. It acts as an antimicrobial preservative with both antibacterial and antifungal properties. Its primary use is in cosmetics and personal care products (such as deodorants, oral care products like mouthwashes and toothpastes) where it inhibits the growth of bacteria, yeasts, and fungi—including Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Aspergillus niger—and helps prolong product shelf life[1][5][7]. It has also been used as a substitute for triclosan in some formulations due to its efficacy at low concentrations[6]. In oral care applications (e.g., Dekasol BL), it helps fight periodontal disease by reducing microbial load[1][5]. o-Cymen-5-ol is approved for use in cosmetics up to 0.1% concentration in the EU and up to 0.5% by CIR/FDA in the US; however, there are stricter restrictions in Japan due to animal neurotoxicity findings[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on o-Cymen-5-ol.